| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $474.0M | -26.6% |
| Cost of Revenue | $50.1M | -22.0% |
| Gross Profit | $423.9M | -27.1% |
| R&D Expense | $134.8M | -4.9% |
| SG&A Expense | $72.0M | -24.2% |
| Operating Income | $1.3M | -98.4% |
| Pre-tax Income | -$6.5M | -109.2% |
| Income Tax | $6.4M | -70.4% |
| Net Income | -$12.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $218.4M | -22.8% |
| Accounts Receivable | $23.5M | -13.9% |
| Current Assets | $543.7M | -3.3% |
| Total Assets | $664.1M | +0.7% |
| Current Liabilities | $81.6M | -3.9% |
| Long-term Debt | $543.6M | +0.2% |
| Total Liabilities | $650.6M | -0.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.7M | -55.7% |
| Capital Expenditures | $922K | +0.4% |
| Investing Cash Flow | -$62.0M | -158.1% |
| Financing Cash Flow | -$48.4M | +68.6% |
| Free Cash Flow | $44.8M | -56.2% |
| -126.2% |
| EPS (Basic) | -$0.13 | -126.5% |
| EPS (Diluted) | -$0.13 | -128.3% |
| Stockholders' Equity |
| $13.4M |
| +60.5% |